Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer

NCT03892642 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Avelumab
BIOLOGICAL: BCG

Sponsor

University of Oklahoma

Collaborators

[object Object]